Anna Berkenblit, Chief Scientific and Medical Officer at Pancreatic Cancer Action Network, shared a post on LinkedIn:
“It is a privilege to join so many leaders in the pancreatic cancer field at ASCO GI26.
To continue the conversation, explore PanCAN’s collaboration with Canopy Cancer Collective to advance the care of pancreatic cancer patients with exocrine pancreatic insufficiency.
We worked together to develop 15 U.S. multidisciplinary consensus statements to improve identification and management of exocrine pancreatic insufficiency across pancreatic cancer care.
Grateful for the opportunity to highlight how collaboration can translate evidence into consistent, patient-centered clinical practice!
I encourage healthcare professionals who care for patients with pancreatic cancer to download the White Paper.”
More posts featuring Anna Berkenblit.